IMCD Toekomstige groei

Future criteriumcontroles 2/6

IMCD zal naar verwachting groeien in winst en omzet met respectievelijk 8.7% en 5.3% per jaar. De winst per aandeel zal naar verwachting groeien met 8.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 17.3% zijn.

Belangrijke informatie

8.7%

Groei van de winst

8.8%

Groei van de winst per aandeel

Trade Distributors winstgroei	8.9%
Inkomstengroei	5.3%
Toekomstig rendement op eigen vermogen	17.3%
Dekking van analisten	Good
Laatst bijgewerkt	18 Nov 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Winst- en omzetgroeiprognoses

BATS-CHIXE:IMCDA - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	5,369	346	440	458	13
12/31/2025	5,063	310	402	423	14
12/31/2024	4,741	278	334	399	14
6/30/2024	4,559	281	361	395	N/A
3/31/2024	4,511	287	372	407	N/A
12/31/2023	4,463	292	383	420	N/A
9/30/2023	4,526	290	386	418	N/A
6/30/2023	4,590	289	390	416	N/A
3/31/2023	4,606	301	334	358	N/A
12/31/2022	4,622	313	278	299	N/A
9/30/2022	4,357	296	213	232	N/A
6/30/2022	4,091	279	149	165	N/A
3/31/2022	3,772	243	163	181	N/A
12/31/2021	3,453	207	178	196	N/A
9/30/2021	3,257	184	211	229	N/A
6/30/2021	3,060	162	244	262	N/A
3/31/2021	2,924	141	229	247	N/A
12/31/2020	2,787	120	214	232	N/A
9/30/2020	2,752	114	183	203	N/A
6/30/2020	2,717	108	152	173	N/A
3/31/2020	2,711	108	154	174	N/A
12/31/2019	2,705	108	156	174	N/A
9/30/2019	2,670	109	141	157	N/A
6/30/2019	2,636	111	126	139	N/A
3/31/2019	2,512	105	114	127	N/A
12/31/2018	2,389	100	102	114	N/A
9/30/2018	2,260	94	87	102	N/A
6/30/2018	2,131	88	73	90	N/A
3/31/2018	2,022	83	N/A	102	N/A
12/31/2017	1,912	77	N/A	114	N/A
9/30/2017	1,840	77	N/A	112	N/A
6/30/2017	1,768	76	N/A	110	N/A
3/31/2017	1,743	75	N/A	105	N/A
12/31/2016	1,718	73	N/A	100	N/A
9/30/2016	1,706	71	N/A	102	N/A
6/30/2016	1,693	69	N/A	104	N/A
3/31/2016	1,615	65	N/A	95	N/A
12/31/2015	1,537	62	N/A	86	N/A
9/30/2015	1,465	57	N/A	79	N/A
6/30/2015	1,392	53	N/A	71	N/A
3/31/2015	1,386	34	N/A	48	N/A
12/31/2014	1,366	20	N/A	37	N/A
9/30/2014	1,350	6	N/A	28	N/A
6/30/2014	1,334	-8	N/A	19	N/A
3/31/2014	1,279	-3	N/A	43	N/A
12/31/2013	1,242	-5	N/A	8	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei IMCDA ( 8.7% per jaar) ligt boven de spaarquote ( 2.1% ).

Winst versus markt: De winst van IMCDA ( 8.7% per jaar) zal naar verwachting langzamer groeien dan de markt UK ( 14.6% per jaar).

Hoge groeiwinsten: De winst van IMCDA zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van IMCDA ( 5.3% per jaar) zal naar verwachting sneller groeien dan de markt UK ( 3.5% per jaar).

Hoge groei-inkomsten: De omzet van IMCDA ( 5.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen IMCDA zal naar verwachting over 3 jaar laag zijn ( 17.3 %).

IMCD Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million.

IMCD N.V. to Report Q1, 2025 Results on Apr 25, 2025

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Blumos Group.

IMCD N.V., Annual General Meeting, Apr 25, 2025

IMCD N.V. Approves Dividend for the Year 2023, Payable on 21 May 2024

Upcoming dividend of €2.24 per share

Full year 2023 earnings released: EPS: €5.14 (vs €5.50 in FY 2022)

IMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024

New minor risk - Insider selling

IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited.

IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board

IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board

IMCD N.V. to Report First Half, 2024 Results on Aug 02, 2024

First half 2023 earnings released: EPS: €2.68 (vs €3.11 in 1H 2022)

IMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc.

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd.

Upcoming dividend of €2.37 per share at 1.6% yield

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd.

IMCD N.V. (ENXTAM:IMCD) entered into an agreement to acquire Parkash DyeChem Private Limited.

IMCD N.V. to Report First Half, 2023 Results on Aug 04, 2023

Now 20% undervalued after recent price drop

Now 22% undervalued

IMCD N.V. (ENXTAM:IMCD) acquired 100% of the shares in Kuni Chemical Co., Ltd.

First half 2022 earnings released

IMCD N.V. to Report Q1, 2023 Results on Apr 26, 2023

IMCD N.V. (ENXTAM:IMCD) has signed an agreement to acquire Welex S.A. Holdings (China) Limited.

IMCD N.V. Appoints Marcus Jordan as Chief Operating Office and New Member of the Management Board

IMCD Stops Its Business in Russia

Upcoming dividend of €1.62 per share

IMCD N.V. Proposes Dividend for the Year 2021

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Quelaris Internacional S.A.

Investor sentiment deteriorated over the past week

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Polychem Handelsgesellschaft M.B.H.

First half 2021 earnings released: EPS €1.85 (vs €1.22 in 1H 2020)

IMCD N.V. (ENXTAM:IMCD) entered into an agreement to acquire Materias Quimicas De Mexico, S.A. De C.V.

Independent Member of Supervisory Board Michel G. Plantevin has left the company

Upcoming dividend of €1.02 per share

IMCD N.V. (ENXTAM:IMCD) acquired Shanghai Yuanhe Chemicals Co., Ltd.

IMCD N.V. (ENXTAM:IMCD) acquired Andes Chemical Corp.

New 90-day high: €112

Full year 2020 earnings released: EPS €2.25 (vs €2.06 in FY 2019)

Revenue beats expectations

Full year 2020 earnings released: EPS €2.25 (vs €2.06 in FY 2019)

Revenue beats expectations

IMCD N.V. Announces Management Changes, Effective 26 February 2021

IMCD N.V. (ENXTAM:IMCD) acquired Millikan S.A. de C.V. and Banner Química S.A. de C.V.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire the personal care business of Ejder Kimya Ilaç Danismanlik Sanayi ve Ticaret A.S.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Pharmaceutical Business of Peak International Products B.V.

IMCD N.V. (ENXTAM:IMCD) acquired Oy Kokko-Fiber Ab.

IMCD N.V. has completed a Follow-on Equity Offering in the amount of €399.999964 million.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Siyeza Fine Chem Propriety Limited.

IMCD N.V. (ENXTAM:IMCD) completed the acquisition of pharmaceutical business of Develing International Trade (Shanghai) Co. Ltd.

IMCD N.V. (ENXTAM:IMCD) acquired VitaQualy Comercio de Ingredientes LTDA.

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven